Irish biomaterials company sold to Ashland for $12m
An Irish company that develops biomaterial solutions for the pharma and medical devices sector has been sold for $12 million to global chemical company Ashland.
Vornia produces a range of medical biomaterials for the pharmaceutical, cosmetic and medical devices industry, as well as for academic and industrial clients. Biomaterials are biological or synthetic substances which can be introduced into body tissue. Vornia’s biomaterial platform technologies can be applied in 3D bioprinting, drug and gene delivery and...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Analysis: Financial and political hurdles could block European Super League
The clubs behind the controversial project face more than a moral backlash — competing commercial interests and the reality of market needs make this more of an uphill battle for those involved than it initially appears
Emer McLysaght: Dazed and confused in a new age of A&E
Our columnist takes a rather thrilling trip to hospital for a headache that just won’t go away
Nadine O’Regan: Will the pandemic finally deliver a revolution in comfort dressing?
Feminism has spent decades telling us to ditch the bra and six-inch heels. But is it possible that change is coming at last?
Brian Keegan: A solidarity tax would be a step backwards
A move to tax those who’ve done well financially during the pandemic has been mooted, but there are good reasons not to touch it